Comparison Chart Unicycive Therapeutics, Inc.
Stocks
UNCY
US90466Y2028
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
07:00:00 28/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 3.610 USD | +0.84% |
|
+2.85% | -37.44% |
| 22/10 | Unicycive Therapeutics Shares Rise After FDA Accepts Resubmitted NDA | DJ |
| 21/10 | Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate New Drug Application Resubmission | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UNICYCIVE THERAPEUTICS, INC. | Bio Therapeutic Drugs | +0.84% | +2.85% | -37.44% | -29.63% | -86.92% | 99.72M |  | | |
- Stock Market
- Stocks
- UNCY Stock
- Charts Unicycive Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
